ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.

Approximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are...

Full description

Saved in:
Bibliographic Details
Main Authors: Anne-Laure Renault, Fabienne Lesueur, Yan Coulombe, Stéphane Gobeil, Penny Soucy, Yosr Hamdi, Sylvie Desjardins, Florence Le Calvez-Kelm, Maxime Vallée, Catherine Voegele, Breast Cancer Family Registry, John L Hopper, Irene L Andrulis, Melissa C Southey, Esther M John, Jean-Yves Masson, Sean V Tavtigian, Jacques Simard
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0156820&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212827997929472
author Anne-Laure Renault
Fabienne Lesueur
Yan Coulombe
Stéphane Gobeil
Penny Soucy
Yosr Hamdi
Sylvie Desjardins
Florence Le Calvez-Kelm
Maxime Vallée
Catherine Voegele
Breast Cancer Family Registry
John L Hopper
Irene L Andrulis
Melissa C Southey
Esther M John
Jean-Yves Masson
Sean V Tavtigian
Jacques Simard
author_facet Anne-Laure Renault
Fabienne Lesueur
Yan Coulombe
Stéphane Gobeil
Penny Soucy
Yosr Hamdi
Sylvie Desjardins
Florence Le Calvez-Kelm
Maxime Vallée
Catherine Voegele
Breast Cancer Family Registry
John L Hopper
Irene L Andrulis
Melissa C Southey
Esther M John
Jean-Yves Masson
Sean V Tavtigian
Jacques Simard
author_sort Anne-Laure Renault
collection DOAJ
description Approximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are involved in the DNA double-strand break repair pathway. ABRAXAS is involved in this pathway and mutations in this gene impair BRCA1 recruitment to DNA damage foci and increase cell sensitivity to ionizing radiation. Moreover, a recurrent germline mutation was reported in Finnish high-risk breast cancer families. To determine if ABRAXAS could be a breast cancer susceptibility gene in other populations, we conducted a population-based case-control mutation screening study of the coding exons and exon/intron boundaries of ABRAXAS in the Breast Cancer Family Registry. In addition to the common variant p.Asp373Asn, sixteen distinct rare variants were identified. Although no significant difference in allele frequencies between cases and controls was observed for the identified variants, two variants, p.Gly39Val and p.Thr141Ile, were shown to diminish phosphorylation of gamma-H2AX in MCF7 human breast adenocarcinoma cells, an important biomarker of DNA double-strand breaks. Overall, likely damaging or neutral variants were evenly represented among cases and controls suggesting that rare variants in ABRAXAS may explain only a small proportion of hereditary breast cancer.
format Article
id doaj-art-e148fbb8c6a249e5924d4efd7f95e9b9
institution OA Journals
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e148fbb8c6a249e5924d4efd7f95e9b92025-08-20T02:09:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015682010.1371/journal.pone.0156820ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.Anne-Laure RenaultFabienne LesueurYan CoulombeStéphane GobeilPenny SoucyYosr HamdiSylvie DesjardinsFlorence Le Calvez-KelmMaxime ValléeCatherine VoegeleBreast Cancer Family RegistryJohn L HopperIrene L AndrulisMelissa C SoutheyEsther M JohnJean-Yves MassonSean V TavtigianJacques SimardApproximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are involved in the DNA double-strand break repair pathway. ABRAXAS is involved in this pathway and mutations in this gene impair BRCA1 recruitment to DNA damage foci and increase cell sensitivity to ionizing radiation. Moreover, a recurrent germline mutation was reported in Finnish high-risk breast cancer families. To determine if ABRAXAS could be a breast cancer susceptibility gene in other populations, we conducted a population-based case-control mutation screening study of the coding exons and exon/intron boundaries of ABRAXAS in the Breast Cancer Family Registry. In addition to the common variant p.Asp373Asn, sixteen distinct rare variants were identified. Although no significant difference in allele frequencies between cases and controls was observed for the identified variants, two variants, p.Gly39Val and p.Thr141Ile, were shown to diminish phosphorylation of gamma-H2AX in MCF7 human breast adenocarcinoma cells, an important biomarker of DNA double-strand breaks. Overall, likely damaging or neutral variants were evenly represented among cases and controls suggesting that rare variants in ABRAXAS may explain only a small proportion of hereditary breast cancer.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0156820&type=printable
spellingShingle Anne-Laure Renault
Fabienne Lesueur
Yan Coulombe
Stéphane Gobeil
Penny Soucy
Yosr Hamdi
Sylvie Desjardins
Florence Le Calvez-Kelm
Maxime Vallée
Catherine Voegele
Breast Cancer Family Registry
John L Hopper
Irene L Andrulis
Melissa C Southey
Esther M John
Jean-Yves Masson
Sean V Tavtigian
Jacques Simard
ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
PLoS ONE
title ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
title_full ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
title_fullStr ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
title_full_unstemmed ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
title_short ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
title_sort abraxas fam175a and breast cancer susceptibility no evidence of association in the breast cancer family registry
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0156820&type=printable
work_keys_str_mv AT annelaurerenault abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT fabiennelesueur abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT yancoulombe abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT stephanegobeil abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT pennysoucy abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT yosrhamdi abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT sylviedesjardins abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT florencelecalvezkelm abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT maximevallee abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT catherinevoegele abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT breastcancerfamilyregistry abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT johnlhopper abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT irenelandrulis abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT melissacsouthey abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT esthermjohn abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT jeanyvesmasson abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT seanvtavtigian abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry
AT jacquessimard abraxasfam175aandbreastcancersusceptibilitynoevidenceofassociationinthebreastcancerfamilyregistry